JPRN-UMIN000046275已完成未知
The effect of dapagliflozin in autosomal dominant polycystic kidney disease patients using tolvaptan: randomized crossover controlled trial - The effect of dapagliflozin in autosomal dominant polycystic kidney disease patients using tolvaptan
Department of Endocrinology, Metabolism and Nephrology, Keio University School of Medicine0 个研究点目标入组 30 人开始时间: 2021年12月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Exclusion criteria are as follows: patients with eGFR less than 25 mL/min/1.73m2; diabetes mellitus (patients who are taking antidiabetic medication or meet the diagnostic criteria for diabetes mellitus); contraindications to the use of dapagliflozin (specifically, the following: patients with a history of hypersensitivity to any of the components of this drug; severe ketosis; diabetic coma, or precoma; severe infections, before and after surgery, or with severe trauma); less than 3 month-use of tolvaptan; deemed unsuitable as subjects by the study investigator.
研究者
相似试验
招募中
1 期
Study of Empagliflozin in Patients with Autosomal Dominant Polycystic Kidney DiseaseMedDRA version: 20.0Level: LLTClassification code: 10032607Term: Other specified cystic kidney disease Class: 10010331MedDRA version: 20.0Level: LLTClassification code: 10011771Term: Cystic kidney disease Class: 10010331Autosomal dominant polycystic kidney diseaseCTIS2023-505890-34-00Medizinische Hochschule Hannover44
尚未招募
4 期
Evaluating the effect of Dapagliflozin on Alanine Transaminase Levels in Type 2 Diabetic Patients with Non Alcoholic Fatty Liver Diseaseon Alcoholic SteatohepatitisNon Alcoholic SteatohepatitisMetabolic and Endocrine - DiabetesOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonType 2 Diabetes MellitusACTRN12624000039583MTI Lady Reading Hospital192
招募中
不适用
Examination of the efficacy of dapagliflozin in patients with type 2 diabetesType 2 diabetesJPRN-UMIN000021954Tonami general hospital Department of diabetes mellitus and endocrinology200
已完成
不适用
Effect of Dapagliflozin in patients with type 2 daibetes mellitusType 2 diabetes mellitusJPRN-UMIN000014922Iwasaki Naika Clinic50
已完成
3 期
Dapagliflozin effects in patients with myocardial infarctioMyocardial infarction.ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarctionIRCT20111206008307N44Tabriz University of Medical Sciences100